1. Astragalin Reduces Hexokinase 2 through Increasing miR-125b to Inhibit the Proliferation of Hepatocellular Carcinoma Cells in Vitro and in Vivo
   Wei Li et al, 2017, J. Agric. Food Chem. CrossRef
2. RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide
   Bin Lu et al, 2018, Cancer Letters CrossRef
3. Valproate sensitizes human glioblastoma cells to 3-bromopyruvate-induced cytotoxicity
   Yuri Ishiguro et al, 2018, International Journal of Pharmaceutics CrossRef
4. Topical 3-bromopyruvate is a novel targeted therapy for melanoma in a preclinical model
   Masayuki Yamada et al, 2018, Journal of Dermatological Science CrossRef
5. The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor Microenvironment
   Je Lin Sieow et al, 2018, Front. Cell Dev. Biol. CrossRef
6. Efficacy of Dual Inhibition of Glycolysis and Glutaminolysis for Therapy of Renal Lesions in Tsc2+/− Mice
   Ashley T. Jones et al, 2019, Neoplasia CrossRef
7. Pifithrin-μ induces necroptosis through oxidative mitochondrial damage but accompanies epithelial–mesenchymal transition-like phenomenon in malignant mesothelioma cells under lactic acidosis
   Yoon-Jin Lee et al, 2019, Arch. Pharm. Res. CrossRef
8. The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view.
   Salah Mohamed El Sayed et al, 2017, Med Hypotheses CrossRef
9. The Contribution of Necroptosis in Neurodegenerative Diseases
   Lifei Shao et al, 2017, Neurochem Res CrossRef
10. A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells
    Thomas C. Chen et al, 2017, Cancer Letters CrossRef
11. 3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2
    Zhou Can et al, 2017, Anti-Cancer Drugs CrossRef
12. 3-Bromopyruvate inhibits the malignant phenotype of malignantly transformed macrophages and dendritic cells induced by glioma stem cells in the glioma microenvironment via miR-449a/MCT1
    Yujing Sheng et al, 2020, Biomedicine & Pharmacotherapy CrossRef
13. Apoptosis and necroptosis-inducing effects of arctigenin on nasal septum carcinoma RPMI-2650 cells in 2D and 3D culture
    Yoon-Jin Lee et al, 2019, Mol. Cell. Toxicol. CrossRef
14. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy
    Mao-Bin Meng et al, 2016, Oncotarget CrossRef
15. Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-bromopyruvate
    Natalia Pieńkowska et al, 2021, IJMS CrossRef
16. Targeting Cancer Metabolism and Current Anti-Cancer Drugs
    Witchuda Sukjoi et al, 2021 CrossRef
17. Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma
    Huimei Huang et al, 2021, Front. Immunol. CrossRef
18. Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer
    Hsin-Chih Yeh et al, 2022, European Journal of Pharmacology CrossRef
19. Targeting Energy Metabolism in Cancer Treatment.
    Joanna Kubik et al, 2022, Int J Mol Sci CrossRef
20. Addressing artifacts of colorimetric anticancer assays for plant-based drug development
    Salma Batool et al, 2022, Med Oncol CrossRef
21. Glucose metabolic reprogramming and modulation in glycerol biosynthesis regulates drug resistance in clinical isolates of Candida
    Sajad Ahmad Padder et al, 2023 CrossRef
22. Glucose Metabolism and Glucose Transporters in Head and Neck Squamous Cell Carcinoma
    Yanyan Ye et al, 2024, Cancer Investigation CrossRef